When Nvidia (NVDA) reported $30 billion in revenue in its second-quarter earnings results, the AI chipmaker disclosed that ...
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with ...
Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Read more here.
Anyone who follows Ryan Reynolds knows he is much more than just a Hollywood A-lister; he is a savvy entrepreneur with a ...